Found: 86
Select item for more details and to access through your institution.
Ten-Year Trends in Sales of Alzheimer Disease Drugs in France Compared With Sales in Germany, Spain, and the UK.
- Published in:
- JAMA Health Forum, 2022, v. 3, n. 8, p. e222253, doi. 10.1001/jamahealthforum.2022.2253
- By:
- Publication type:
- Article
Response to the Comment on "Plasma Leptin Is Associated With Amyloid CSF Biomarkers and Alzheimer's Disease Diagnosis in Cognitively Impaired Patients".
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Plasma leptin is associated with amyloid CSF biomarkers and Alzheimer's disease diagnosis in cognitively impaired patients.
- Published in:
- Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 2023, v. 78, n. 4, p. 645, doi. 10.1093/gerona/glac234
- By:
- Publication type:
- Article
Gait Speed and Decline in Gait Speed as Predictors of Incident Dementia.
- Published in:
- 2017
- By:
- Publication type:
- journal article
CSF Aβ<sub>1-42</sub> Levels and Glucose Metabolism in Alzheimer's Disease>.
- Published in:
- Journal of Alzheimer's Disease, 2011, v. 27, n. 4, p. 845, doi. 10.3233/JAD-2011-111007
- By:
- Publication type:
- Article
Plasma neuregulin 1 as a synaptic biomarker in Alzheimer's disease: a discovery cohort study.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01014-7
- By:
- Publication type:
- Article
COVID-19 in adults with dementia: clinical features and risk factors of mortality—a clinical cohort study on 125 patients.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00820-9
- By:
- Publication type:
- Article
Hyperuricemia, Gout, and the Brain—an Update.
- Published in:
- Current Rheumatology Reports, 2021, v. 23, n. 12, p. 1, doi. 10.1007/s11926-021-01050-6
- By:
- Publication type:
- Article
Pro-apoptotic kinase levels in cerebrospinal fluid as potential future biomarkers in Alzheimer's disease.
- Published in:
- Frontiers in Neurology, 2015, p. 1, doi. 10.3389/fneur.2015.00168
- By:
- Publication type:
- Article
PKR involvement in Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2017, v. 9, p. 1, doi. 10.1186/s13195-017-0308-0
- By:
- Publication type:
- Article
The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2016, v. 8, p. 1, doi. 10.1186/s13195-016-0208-8
- By:
- Publication type:
- Article
Utility of CSF biomarkers in psychiatric disorders: a national multicentre prospective study.
- Published in:
- Alzheimer's Research & Therapy, 2016, v. 8, p. 1, doi. 10.1186/s13195-016-0192-z
- By:
- Publication type:
- Article
Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study.
- Published in:
- Alzheimer's Research & Therapy, 2015, v. 7, n. 1, p. 1, doi. 10.1186/s13195-015-0114-5
- By:
- Publication type:
- Article
A diagnostic scale for Alzheimer's disease based on cerebrospinal fluid biomarker profiles.
- Published in:
- Alzheimer's Research & Therapy, 2014, v. 6, n. 3, p. 1, doi. 10.1186/alzrt267
- By:
- Publication type:
- Article
Cerebrospinal fluid neurogranin in Alzheimer's disease studies: are immunoassay results interchangeable?
- Published in:
- 2022
- By:
- Publication type:
- Letter
Cerebrospinal Fluid Alpha-Synuclein Improves the Differentiation between Dementia with Lewy Bodies and Alzheimer's Disease in Clinical Practice.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 21, p. 13488, doi. 10.3390/ijms232113488
- By:
- Publication type:
- Article
Risk prediction models for dementia: role of age and cardiometabolic risk factors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease.
- Published in:
- Acta Neuropathologica, 2024, v. 147, n. 1, p. 1, doi. 10.1007/s00401-023-02659-w
- By:
- Publication type:
- Article
Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer's disease.
- Published in:
- Acta Neuropathologica, 2022, v. 144, n. 5, p. 843, doi. 10.1007/s00401-022-02469-6
- By:
- Publication type:
- Article
Quel est l'intérêt aujourd'hui des biomarqueurs de la maladie d'Alzheimer, chez les patients âgés et très âgés ?
- Published in:
- Gériatrie et Psychologie Neuropsychiatrie du Vieillissement, 2019, v. 17, n. 1, p. 65, doi. 10.1684/pnv.2019.0779
- By:
- Publication type:
- Article
Current status and quantitative results of the AMYPAD prognostic and natural history study: Neuroimaging / Optimal neuroimaging measures for tracking disease progression.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044711
- By:
- Publication type:
- Article
Memory assessment in illiterate patients: The diagnostic value of the TNI 93: Neuropsychology/Neuropsychological profiles of dementia: Valid biomarkers?
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.042059
- By:
- Publication type:
- Article
CSF levels of the BACE1 substrate Neuregulin1 correlate with cognition and synaptic biomarkers in Alzheimer's disease: Biomarkers (non‐neuroimaging) / Novel biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.037097
- By:
- Publication type:
- Article
O3‐12‐03: THE CSF SYNAPTIC BIOMARKER BACE1 CORRELATES WITH COGNITION IN MCI AND ALZHEIRMER DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P916, doi. 10.1016/j.jalz.2019.06.4692
- By:
- Publication type:
- Article
O2‐05‐01: CEREBROSPINAL FLUID SYNAPTIC VESICLE GLYCOPROTEIN 2A IN ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P545, doi. 10.1016/j.jalz.2019.06.4475
- By:
- Publication type:
- Article
O3‐14‐06: DISSECTION OF SYNAPTIC PATHWAYS THROUGH THE ANALYSIS OF BIOMARKERS IN THE CSF: A COMBINING TOOL FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1061, doi. 10.1016/j.jalz.2018.06.2854
- By:
- Publication type:
- Article
CLINICAL IMPACT OF CEREBROSPINAL FLUID BIOMARKERS IN MILD COGNITIVE IMPAIRMENT DIAGNOSIS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P336, doi. 10.1016/j.jalz.2017.06.060
- By:
- Publication type:
- Article
CLINICAL PROFILE OF PATIENTS WITH NORMAL CSF Aβ42 AND Aβ42/Aβ40 RATIO, YET ABNORMAL CSF 181P-TAU: A SNAP STORY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P343, doi. 10.1016/j.jalz.2017.06.267
- By:
- Publication type:
- Article
Entorhinal, parahippocampal, and inferior temporal F18-T807 SUVR correlates with CSF total tau and tau T181P in cognitively normal elderly.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P109, doi. 10.1016/j.jalz.2015.06.185
- By:
- Publication type:
- Article
Entorhinal, parahippocampal, and inferior temporal F18-T807 SUVR correlates with CSF total tau and tau T181P in cognitively normal elderly.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P267, doi. 10.1016/j.jalz.2015.06.185
- By:
- Publication type:
- Article
Impact of harmonization of collection tubes on Alzheimer's disease diagnosis.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2014, v. 10, n. 5, p. S390, doi. 10.1016/j.jalz.2013.06.008
- By:
- Publication type:
- Article
Impact of cerebrospinal fluid biomarkers of alzheimer's disease in clinical practice: a multicentric study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2014, v. 10, p. P146, doi. 10.1016/j.jalz.2014.04.104
- By:
- Publication type:
- Article
Intersite variability of CSF Alzheimer’s disease biomarkers in clinical setting.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2013, v. 9, n. 4, p. 406, doi. 10.1016/j.jalz.2012.06.006
- By:
- Publication type:
- Article
CSF Aβ 1-42 levels and glucose metabolism in Alzheimer's disease
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Increased cerebrospinal fluid levels of double-stranded RNA-dependant protein kinase in Alzheimer's disease
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Role of the PKR-eIF2α pathway in BACE1 levels Relevance in Alzheimer's disease
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Long-term amnesia following electroconvulsive therapy
- Published in:
- 2011
- By:
- Publication type:
- Abstract
CSF biomarker cut-offs for the diagnosis of Alzheimer's disease in a memory clinical center
- Published in:
- 2011
- By:
- Publication type:
- Abstract
CADASIL-Like MRI Hyperintensities in a Case of Neuropathologically Confirmed Alzheimer’s Disease
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Behavioral variant of Alzheimer's disease in an old woman mimicking frontotemporal dementia: Diagnosis contribution of CSF biomarkers
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Correlations between cognitive tests and CSF biomarkers in Alzheimer's disease
- Published in:
- 2010
- By:
- Publication type:
- Abstract
A case series of alcoholic patients with episodic memory impairment resembling Alzheimer's disease: the use of CSF biomarkers
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Education level and CSF biomarkers in Alzheimer's disease: The cognitive reserve theory
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Using virtual reality in lumbar puncture training improves students learning experience.
- Published in:
- BMC Medical Education, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12909-022-03317-7
- By:
- Publication type:
- Article
Comparison of CSF and plasma NfL and pNfH for Alzheimer's disease diagnosis: a memory clinic study.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 3, p. 1297, doi. 10.1007/s00415-023-12066-6
- By:
- Publication type:
- Article
The screening of Alzheimer's patients with CSF biomarkers, modulates the distribution of APOE genotype: impact on clinical trials.
- Published in:
- Journal of Neurology, 2014, v. 261, n. 6, p. 1187, doi. 10.1007/s00415-014-7335-6
- By:
- Publication type:
- Article
Impact of cerebro-spinal fluid biomarkers of Alzheimer's disease in clinical practice: a multicentric study.
- Published in:
- Journal of Neurology, 2014, v. 261, n. 1, p. 144, doi. 10.1007/s00415-013-7160-3
- By:
- Publication type:
- Article
Change in Fast Walking Speed Preceding Death: Results From a Prospective Longitudinal Cohort Study.
- Published in:
- Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 2014, v. 69A, n. 3, p. 354, doi. 10.1093/gerona/glt114
- By:
- Publication type:
- Article
Lipid-Lowering Drugs Associated With Slower Motor Decline in the Elderly Adults.
- Published in:
- Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 2014, v. 69A, n. 2, p. 199, doi. 10.1093/gerona/glt140
- By:
- Publication type:
- Article
Neurofilaments as Emerging Biomarkers of Neuroaxonal Damage to Differentiate Behavioral Frontotemporal Dementia from Primary Psychiatric Disorders: A Systematic Review.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 5, p. 754, doi. 10.3390/diagnostics11050754
- By:
- Publication type:
- Article